Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP918228.RAB-d74xyhafAGbZU_dQXQ4EuH9VrPCeC_-wQ5AVuFGAc130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918228.RAB-d74xyhafAGbZU_dQXQ4EuH9VrPCeC_-wQ5AVuFGAc130_provenance.
• NP521773.RAojQL3NOV0fLOKcmoof9rubBP8fcKMP-Nsdsa9nfqx8w130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521773.RAojQL3NOV0fLOKcmoof9rubBP8fcKMP-Nsdsa9nfqx8w130_provenance.
• NP951704.RAlJSqYofivw-oMmlYw3HOi-KGH7o4IwZBtldwF4l9zvg130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951704.RAlJSqYofivw-oMmlYw3HOi-KGH7o4IwZBtldwF4l9zvg130_provenance.
• NP930818.RALqx7Jt8LhgXl7k166XgG5Ev9oWkXdULvruvHonbodro130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930818.RALqx7Jt8LhgXl7k166XgG5Ev9oWkXdULvruvHonbodro130_provenance.
• NP710337.RAYPAHkWQkRkFAonbVUVLGYmJ8sjP9MVcHSbe3EuDzEak130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710337.RAYPAHkWQkRkFAonbVUVLGYmJ8sjP9MVcHSbe3EuDzEak130_provenance.
• NP710338.RASFy1hKM4dsT209v43hMZsQmPX29ZNDFuoslrr63nUSI130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710338.RASFy1hKM4dsT209v43hMZsQmPX29ZNDFuoslrr63nUSI130_provenance.
• NP710339.RAf9dnLQRxZhftCBCz5lVn2SLUuvuLMO18xhe-ntCRDJA130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710339.RAf9dnLQRxZhftCBCz5lVn2SLUuvuLMO18xhe-ntCRDJA130_provenance.
• NP710336.RAC4tRQpJrG04Klh8G9WyCIZToIi3JBK_-I3EeVSD2b0c130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710336.RAC4tRQpJrG04Klh8G9WyCIZToIi3JBK_-I3EeVSD2b0c130_provenance.
• NP613826.RAjnpDwQ2gsUttGzfWjCbRV2uInfkq8wooxqDzccgUNP0130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613826.RAjnpDwQ2gsUttGzfWjCbRV2uInfkq8wooxqDzccgUNP0130_provenance.
• NP613906.RA8I8_dSQyB5IYAVn_m7XcQV1X1fUpSmr6x4GKxhJZYpk130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613906.RA8I8_dSQyB5IYAVn_m7XcQV1X1fUpSmr6x4GKxhJZYpk130_provenance.
• NP951639.RAEstysOg34TXs3g2yHNFIzphuFN0dOL8Ha5uG2Q4oY-M130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951639.RAEstysOg34TXs3g2yHNFIzphuFN0dOL8Ha5uG2Q4oY-M130_provenance.
• NP951719.RAxsCpTcUw-_bUKwWERGIBsd-fuKwyoLSM7JHKhHJO-r8130_assertion description "[Despite patients with FIP1-like-1-platelet-derived growth factor alpha (FIP1L1-PDGFRA) associated HES (myeloid neoplasms associated with PDGFRA rearrangement) have been shown to respond to low-dose imatinib with a complete and durable hematological and cytogenetic remission, influences of imatinib on clinical manifestations related to hypereosinophilia heart involvement are variable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951719.RAxsCpTcUw-_bUKwWERGIBsd-fuKwyoLSM7JHKhHJO-r8130_provenance.